Skip to main content
logo
Axsome Therapeutics, Inc. (FRA:19X)
Germany flag Germany · Delayed Price · Currency is EUR
129.20
+1.15 (0.90%)
Last updated: Dec 1, 2025, 8:05 AM CET

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Novel Therapies for the Management of Central Nervous System Disorders
385.69M
Log In
Log In
Novel Therapies for the Management of Central Nervous System Disorders Growth
42.53%
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
United States
378.16M
Log In
Log In
United States Growth
91.74%
Log In
Log In
Non-United States
7.53M
Log In
Log In
Non-United States Growth
-89.73%
Log In
Log In